Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 78 entries
Sorted by: Best Match Show Resources per page
14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts.

Breast care (Basel, Switzerland)

Jackisch C, Harbeck N, Huober J, von Minckwitz G, Gerber B, Kreipe HH, Liedtke C, Marschner N, Möbus V, Scheithauer H, Schneeweiss A, Thomssen C, Loibl S, Beckmann MW, Blohmer JU, Costa SD, Decker T, Diel I, Fasching PA, Fehm T, Janni W, Lück HJ, Maass N, Scharl A, Untch M.
PMID: 26557827
Breast Care (Basel). 2015 Jul;10(3):211-9. doi: 10.1159/000433590. Epub 2015 Jun 23.

The key topics of this year's 14th St. Gallen Consensus Conference on the diagnosis and therapy of primary breast cancer were again questions about breast surgery and axillary surgery, radio-oncology and systemic therapy options in consideration of tumor biology,...

Cite
Jackisch C, Harbeck N, Huober J, et al. 14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts. Breast Care (Basel). 2015;10(3):211-9doi: 10.1159/000433590.
Jackisch, C., Harbeck, N., Huober, J., von Minckwitz, G., Gerber, B., Kreipe, H. H., Liedtke, C., Marschner, N., Möbus, V., Scheithauer, H., Schneeweiss, A., Thomssen, C., Loibl, S., Beckmann, M. W., Blohmer, J. U., Costa, S. D., Decker, T., Diel, I., Fasching, P. A., Fehm, T., Janni, W., Lück, H. J., Maass, N., Scharl, A., & Untch, M. (2015). 14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts. Breast care (Basel, Switzerland), 10(3), 211-9. https://doi.org/10.1159/000433590
Jackisch, Christian, et al. "14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts." Breast care (Basel, Switzerland) vol. 10,3 (2015): 211-9. doi: https://doi.org/10.1159/000433590
Jackisch C, Harbeck N, Huober J, von Minckwitz G, Gerber B, Kreipe HH, Liedtke C, Marschner N, Möbus V, Scheithauer H, Schneeweiss A, Thomssen C, Loibl S, Beckmann MW, Blohmer JU, Costa SD, Decker T, Diel I, Fasching PA, Fehm T, Janni W, Lück HJ, Maass N, Scharl A, Untch M. 14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts. Breast Care (Basel). 2015 Jul;10(3):211-9. doi: 10.1159/000433590. Epub 2015 Jun 23. PMID: 26557827; PMCID: PMC4569213.
Copy Download .nbib Format: NLM
Expression of leukemia inhibitory factor in craniopharyngioma.

Endocrine pathology

Tran A, Kovacs K, Stefaneanu L, Kontogeorgos G, Scheithauer BW, Melmed S.
PMID: 27519214
Endocr Pathol. 1999 Jun;10(2):103-8. doi: 10.1007/BF02739822.

It has recently been reported that overexpression of leukemia inhibitory factor (LIF) in mice transgenic for LIF causes invagination of the anterior wall of Rathke's pouch leading to the formation of cysts lined by LIF immunoreactive epithelial cells. Strong...

Cite
Tran A, Kovacs K, Stefaneanu L, et al. Expression of leukemia inhibitory factor in craniopharyngioma. Endocr Pathol. 1999;10(2):103-8doi: 10.1007/BF02739822.
Tran, A., Kovacs, K., Stefaneanu, L., Kontogeorgos, G., Scheithauer, B. W., & Melmed, S. (1999). Expression of leukemia inhibitory factor in craniopharyngioma. Endocrine pathology, 10(2), 103-8. https://doi.org/10.1007/BF02739822
Tran, A, et al. "Expression of leukemia inhibitory factor in craniopharyngioma." Endocrine pathology vol. 10,2 (1999): 103-8. doi: https://doi.org/10.1007/BF02739822
Tran A, Kovacs K, Stefaneanu L, Kontogeorgos G, Scheithauer BW, Melmed S. Expression of leukemia inhibitory factor in craniopharyngioma. Endocr Pathol. 1999 Jun;10(2):103-8. doi: 10.1007/BF02739822. PMID: 27519214.
Copy Download .nbib Format: NLM
Localization of vascular endothelial growth factor in nontumorous human pituitaries.

Endocrine pathology

Vidal S, Kovacs K, Cohen SM, Stefaneanu L, Lloyd RV, Scheithauer BW.
PMID: 27519215
Endocr Pathol. 1999 Jun;10(2):109-22. doi: 10.1007/BF02739823.

Vascular endothelial growth factor (VEGF) is a key mediator of endothelial cell proliferation, angiogenesis, and vascular permeability. Our aim was to investigate whether VEGF is expressed in various cell types of the human pituitary. Eight nontumorous pituitaries were investigated...

Cite
Vidal S, Kovacs K, Cohen SM, et al. Localization of vascular endothelial growth factor in nontumorous human pituitaries. Endocr Pathol. 1999;10(2):109-22doi: 10.1007/BF02739823.
Vidal, S., Kovacs, K., Cohen, S. M., Stefaneanu, L., Lloyd, R. V., & Scheithauer, B. W. (1999). Localization of vascular endothelial growth factor in nontumorous human pituitaries. Endocrine pathology, 10(2), 109-22. https://doi.org/10.1007/BF02739823
Vidal, S, et al. "Localization of vascular endothelial growth factor in nontumorous human pituitaries." Endocrine pathology vol. 10,2 (1999): 109-22. doi: https://doi.org/10.1007/BF02739823
Vidal S, Kovacs K, Cohen SM, Stefaneanu L, Lloyd RV, Scheithauer BW. Localization of vascular endothelial growth factor in nontumorous human pituitaries. Endocr Pathol. 1999 Jun;10(2):109-22. doi: 10.1007/BF02739823. PMID: 27519215.
Copy Download .nbib Format: NLM
The Immunophenotype of Pituitary Adenomas.

Endocrine pathology

Lloyd RV, Scheithauer BW, Kovacs K, Roche PC.
PMID: 12114642
Endocr Pathol. 1996;7(2):145-150. doi: 10.1007/BF02739974.

Although the production of pituitary hormones by adenohypophysial tumors has been studied extensively, an examination of the immunophenotype of pituitary adenomas using a broad spectrum of antibodies has not been previously investigated. We studied 23 pituitary adenomas using a...

Cite
Lloyd RV, Scheithauer BW, Kovacs K, et al. The Immunophenotype of Pituitary Adenomas. Endocr Pathol. 1996;7(2):145-150doi: 10.1007/BF02739974.
Lloyd, R. V., Scheithauer, B. W., Kovacs, K., & Roche, P. C. (1996). The Immunophenotype of Pituitary Adenomas. Endocrine pathology, 7(2), 145-150. https://doi.org/10.1007/BF02739974
Lloyd, Ricardo V., et al. "The Immunophenotype of Pituitary Adenomas." Endocrine pathology vol. 7,2 (1996): 145-150. doi: https://doi.org/10.1007/BF02739974
Lloyd RV, Scheithauer BW, Kovacs K, Roche PC. The Immunophenotype of Pituitary Adenomas. Endocr Pathol. 1996;7(2):145-150. doi: 10.1007/BF02739974. PMID: 12114642.
Copy Download .nbib Format: NLM
Vasculature in Nontumorous Hypophyses, Pituitary Adenomas, and Carcinomas: A Quantitative Morphologic Study.

Endocrine pathology

Jugenburg M, Kovacs K, Stefaneanu L, Scheithauer BW.
PMID: 12114647
Endocr Pathol. 1995;6(2):115-124. doi: 10.1007/BF02739874.

Vascular supply is essential for tumor proliferation and metastasis formation. Correlation was noted between vascular density and tumor size as well as metastases in several tumor types. The aim of the present study was to assess vascular density in...

Cite
Jugenburg M, Kovacs K, Stefaneanu L, et al. Vasculature in Nontumorous Hypophyses, Pituitary Adenomas, and Carcinomas: A Quantitative Morphologic Study. Endocr Pathol. 1995;6(2):115-124doi: 10.1007/BF02739874.
Jugenburg, M., Kovacs, K., Stefaneanu, L., & Scheithauer, B. W. (1995). Vasculature in Nontumorous Hypophyses, Pituitary Adenomas, and Carcinomas: A Quantitative Morphologic Study. Endocrine pathology, 6(2), 115-124. https://doi.org/10.1007/BF02739874
Jugenburg, Martin, et al. "Vasculature in Nontumorous Hypophyses, Pituitary Adenomas, and Carcinomas: A Quantitative Morphologic Study." Endocrine pathology vol. 6,2 (1995): 115-124. doi: https://doi.org/10.1007/BF02739874
Jugenburg M, Kovacs K, Stefaneanu L, Scheithauer BW. Vasculature in Nontumorous Hypophyses, Pituitary Adenomas, and Carcinomas: A Quantitative Morphologic Study. Endocr Pathol. 1995;6(2):115-124. doi: 10.1007/BF02739874. PMID: 12114647.
Copy Download .nbib Format: NLM
Pituitary Changes in Ataxia-Telangiectasia Syndrome: An Immunocytochemical, In Situ Hybridization, and DNA Cytometric Study of Three Cases.

Endocrine pathology

Kovacs K, Giannini C, Scheithauer BW, Stefaneanu L, Lloyd RV, Horvath E.
PMID: 12114723
Endocr Pathol. 1997;8(3):195-203. doi: 10.1007/BF02738786.

Ataxia-telangiectasia (AT) syndrome (cerebellar ataxia, oculocutaneous telangiectasias, immunodeficiency, susceptibility to infections, and neoplasia) is associated with cyto- and nucleomegaly in several organ systems. Our aim was to determine (1) whether such cellular abnormalities in the pituitary selectively involve specific...

Cite
Kovacs K, Giannini C, Scheithauer BW, et al. Pituitary Changes in Ataxia-Telangiectasia Syndrome: An Immunocytochemical, In Situ Hybridization, and DNA Cytometric Study of Three Cases. Endocr Pathol. 1997;8(3):195-203doi: 10.1007/BF02738786.
Kovacs, K., Giannini, C., Scheithauer, B. W., Stefaneanu, L., Lloyd, R. V., & Horvath, E. (1997). Pituitary Changes in Ataxia-Telangiectasia Syndrome: An Immunocytochemical, In Situ Hybridization, and DNA Cytometric Study of Three Cases. Endocrine pathology, 8(3), 195-203. https://doi.org/10.1007/BF02738786
Kovacs, Kalman, et al. "Pituitary Changes in Ataxia-Telangiectasia Syndrome: An Immunocytochemical, In Situ Hybridization, and DNA Cytometric Study of Three Cases." Endocrine pathology vol. 8,3 (1997): 195-203. doi: https://doi.org/10.1007/BF02738786
Kovacs K, Giannini C, Scheithauer BW, Stefaneanu L, Lloyd RV, Horvath E. Pituitary Changes in Ataxia-Telangiectasia Syndrome: An Immunocytochemical, In Situ Hybridization, and DNA Cytometric Study of Three Cases. Endocr Pathol. 1997;8(3):195-203. doi: 10.1007/BF02738786. PMID: 12114723.
Copy Download .nbib Format: NLM
Attention-deficit hyperactivity disorder (ADHD) stimulant medications as cognitive enhancers.

Frontiers in neuroscience

Advokat C, Scheithauer M.
PMID: 23754970
Front Neurosci. 2013 May 29;7:82. doi: 10.3389/fnins.2013.00082. eCollection 2013.

Recent increases in attention deficit hyperactivity disorder (ADHD) diagnoses, and the escalation of stimulant prescriptions, has raised concern about diversion and abuse of stimulants, as well as the ethics of using these drugs as "cognitive enhancers."Such concern appears misplaced...

Cite
Advokat C, Scheithauer M. Attention-deficit hyperactivity disorder (ADHD) stimulant medications as cognitive enhancers. Front Neurosci. 2013;7:82doi: 10.3389/fnins.2013.00082.
Advokat, C., & Scheithauer, M. (2013). Attention-deficit hyperactivity disorder (ADHD) stimulant medications as cognitive enhancers. Frontiers in neuroscience, 782. https://doi.org/10.3389/fnins.2013.00082
Advokat, Claire, and Scheithauer, Mindy. "Attention-deficit hyperactivity disorder (ADHD) stimulant medications as cognitive enhancers." Frontiers in neuroscience vol. 7 (2013): 82. doi: https://doi.org/10.3389/fnins.2013.00082
Advokat C, Scheithauer M. Attention-deficit hyperactivity disorder (ADHD) stimulant medications as cognitive enhancers. Front Neurosci. 2013 May 29;7:82. doi: 10.3389/fnins.2013.00082. eCollection 2013. PMID: 23754970; PMCID: PMC3666055.
Copy Download .nbib Format: NLM
Interaction between the cytostatic effects of quercetin and 5-fluorouracil in two human colorectal cancer cell lines.

Phytomedicine : international journal of phytotherapy and phytopharmacology

Boersma HH, Woerdenbag HJ, Bauer J, Scheithauer W, Kampinga HH, Konings AW.
PMID: 23195945
Phytomedicine. 1994 Dec;1(3):239-44. doi: 10.1016/S0944-7113(11)80071-1.

Therapy with 5-fluorouracil (5-FU) as a single agent has only limited success in palliative treatment of cancer of the large bowel. In the current study, the effect of quercetin on the action of 5-FU in the human colorectal cancer...

Cite
Boersma HH, Woerdenbag HJ, Bauer J, et al. Interaction between the cytostatic effects of quercetin and 5-fluorouracil in two human colorectal cancer cell lines. Phytomedicine. 1994;1(3):239-44doi: 10.1016/S0944-7113(11)80071-1.
Boersma, H. H., Woerdenbag, H. J., Bauer, J., Scheithauer, W., Kampinga, H. H., & Konings, A. W. (1994). Interaction between the cytostatic effects of quercetin and 5-fluorouracil in two human colorectal cancer cell lines. Phytomedicine : international journal of phytotherapy and phytopharmacology, 1(3), 239-44. https://doi.org/10.1016/S0944-7113(11)80071-1
Boersma, H H, et al. "Interaction between the cytostatic effects of quercetin and 5-fluorouracil in two human colorectal cancer cell lines." Phytomedicine : international journal of phytotherapy and phytopharmacology vol. 1,3 (1994): 239-44. doi: https://doi.org/10.1016/S0944-7113(11)80071-1
Boersma HH, Woerdenbag HJ, Bauer J, Scheithauer W, Kampinga HH, Konings AW. Interaction between the cytostatic effects of quercetin and 5-fluorouracil in two human colorectal cancer cell lines. Phytomedicine. 1994 Dec;1(3):239-44. doi: 10.1016/S0944-7113(11)80071-1. PMID: 23195945.
Copy Download .nbib Format: NLM
Prolactinomas: diagnosis and treatment.

Expert review of endocrinology & metabolism

Nassiri F, Cusimano MD, Scheithauer BW, Rotondo F, Fazio A, Syro LV, Kovacs K, Lloyd RV.
PMID: 30764014
Expert Rev Endocrinol Metab. 2012 Mar;7(2):233-241. doi: 10.1586/eem.12.4.

Pituitary lactotrophs secrete prolactin. This process is enhanced by estrogen and inhibited by dopamine. Prolactinomas are benign neoplasms that rarely increase in size and are classified according to size as microadenomas (10 mm diameter). The clinical features of prolactinomas...

Cite
Nassiri F, Cusimano MD, Scheithauer BW, et al. Prolactinomas: diagnosis and treatment. Expert Rev Endocrinol Metab. 2012;7(2):233-241doi: 10.1586/eem.12.4.
Nassiri, F., Cusimano, M. D., Scheithauer, B. W., Rotondo, F., Fazio, A., Syro, L. V., Kovacs, K., & Lloyd, R. V. (2012). Prolactinomas: diagnosis and treatment. Expert review of endocrinology & metabolism, 7(2), 233-241. https://doi.org/10.1586/eem.12.4
Nassiri, Farshad, et al. "Prolactinomas: diagnosis and treatment." Expert review of endocrinology & metabolism vol. 7,2 (2012): 233-241. doi: https://doi.org/10.1586/eem.12.4
Nassiri F, Cusimano MD, Scheithauer BW, Rotondo F, Fazio A, Syro LV, Kovacs K, Lloyd RV. Prolactinomas: diagnosis and treatment. Expert Rev Endocrinol Metab. 2012 Mar;7(2):233-241. doi: 10.1586/eem.12.4. PMID: 30764014.
Copy Download .nbib Format: NLM
Same but Different? Developmental Pathways to Demonstrative Targeted Attacks - Qualitative Case Analyses of Adolescent and Young Adult Perpetrators of Targeted School Attacks and Jihadi Terrorist Attacks in Germany.

International journal of developmental science

Böckler N, Leuschner V, Zick A, Scheithauer H.
PMID: 30221119
Int J Dev Sci. 2018 Sep 05;12(1):5-24. doi: 10.3233/DEV-180255.

Analysis of incidents over the past ten years in Germany reveals that the boundaries between targeted attacks in schools and terrorist attacks are starting to blur. Böckler, Leuschner, Roth, Zick, and Scheithauer (2018) recently presented a set of hypotheses...

Cite
Böckler N, Leuschner V, Zick A, et al. Same but Different? Developmental Pathways to Demonstrative Targeted Attacks - Qualitative Case Analyses of Adolescent and Young Adult Perpetrators of Targeted School Attacks and Jihadi Terrorist Attacks in Germany. Int J Dev Sci. 2018;12(1):5-24doi: 10.3233/DEV-180255.
Böckler, N., Leuschner, V., Zick, A., & Scheithauer, H. (2018). Same but Different? Developmental Pathways to Demonstrative Targeted Attacks - Qualitative Case Analyses of Adolescent and Young Adult Perpetrators of Targeted School Attacks and Jihadi Terrorist Attacks in Germany. International journal of developmental science, 12(1), 5-24. https://doi.org/10.3233/DEV-180255
Böckler, Nils, et al. "Same but Different? Developmental Pathways to Demonstrative Targeted Attacks - Qualitative Case Analyses of Adolescent and Young Adult Perpetrators of Targeted School Attacks and Jihadi Terrorist Attacks in Germany." International journal of developmental science vol. 12,1 (2018): 5-24. doi: https://doi.org/10.3233/DEV-180255
Böckler N, Leuschner V, Zick A, Scheithauer H. Same but Different? Developmental Pathways to Demonstrative Targeted Attacks - Qualitative Case Analyses of Adolescent and Young Adult Perpetrators of Targeted School Attacks and Jihadi Terrorist Attacks in Germany. Int J Dev Sci. 2018 Sep 05;12(1):5-24. doi: 10.3233/DEV-180255. PMID: 30221119; PMCID: PMC6130415.
Copy Download .nbib Format: NLM
Transmission Risk on a Neonatal Intensive Care Unit: .

The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale

Artelt T, Kaase M, Bley I, Eiffert H, Mellmann A, Küster H, Lange M, Scheithauer S.
PMID: 29854033
Can J Infect Dis Med Microbiol. 2018 Apr 29;2018:1525072. doi: 10.1155/2018/1525072. eCollection 2018.

Isolation precautions required for neonatal intensive care units are part of a bundle with the aim to prevent transmission, colonization, and infection with multidrug-resistant gram-negative pathogens as neonates face an increased risk of mortality and morbidity in case of...

Cite
Artelt T, Kaase M, Bley I, et al. Transmission Risk on a Neonatal Intensive Care Unit: . Can J Infect Dis Med Microbiol. 2018;2018:1525072doi: 10.1155/2018/1525072.
Artelt, T., Kaase, M., Bley, I., Eiffert, H., Mellmann, A., Küster, H., Lange, M., & Scheithauer, S. (2018). Transmission Risk on a Neonatal Intensive Care Unit: . The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale, 20181525072. https://doi.org/10.1155/2018/1525072
Artelt, Tanja, et al. "Transmission Risk on a Neonatal Intensive Care Unit: ." The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale vol. 2018 (2018): 1525072. doi: https://doi.org/10.1155/2018/1525072
Artelt T, Kaase M, Bley I, Eiffert H, Mellmann A, Küster H, Lange M, Scheithauer S. Transmission Risk on a Neonatal Intensive Care Unit: . Can J Infect Dis Med Microbiol. 2018 Apr 29;2018:1525072. doi: 10.1155/2018/1525072. eCollection 2018. PMID: 29854033; PMCID: PMC5949198.
Copy Download .nbib Format: NLM
An Innovate Robotic Endoscope Guidance System for Transnasal Sinus and Skull Base Surgery: Proof of Concept.

Journal of neurological surgery. Part B, Skull base

Friedrich DT, Sommer F, Scheithauer MO, Greve J, Hoffmann TK, Schuler PJ.
PMID: 29134165
J Neurol Surg B Skull Base. 2017 Dec;78(6):466-472. doi: 10.1055/s-0037-1603974. Epub 2017 Jul 21.

No abstract available.

Cite
Friedrich DT, Sommer F, Scheithauer MO, et al. An Innovate Robotic Endoscope Guidance System for Transnasal Sinus and Skull Base Surgery: Proof of Concept. J Neurol Surg B Skull Base. 2017;78(6):466-472doi: 10.1055/s-0037-1603974.
Friedrich, D. T., Sommer, F., Scheithauer, M. O., Greve, J., Hoffmann, T. K., & Schuler, P. J. (2017). An Innovate Robotic Endoscope Guidance System for Transnasal Sinus and Skull Base Surgery: Proof of Concept. Journal of neurological surgery. Part B, Skull base, 78(6), 466-472. https://doi.org/10.1055/s-0037-1603974
Friedrich, D T, et al. "An Innovate Robotic Endoscope Guidance System for Transnasal Sinus and Skull Base Surgery: Proof of Concept." Journal of neurological surgery. Part B, Skull base vol. 78,6 (2017): 466-472. doi: https://doi.org/10.1055/s-0037-1603974
Friedrich DT, Sommer F, Scheithauer MO, Greve J, Hoffmann TK, Schuler PJ. An Innovate Robotic Endoscope Guidance System for Transnasal Sinus and Skull Base Surgery: Proof of Concept. J Neurol Surg B Skull Base. 2017 Dec;78(6):466-472. doi: 10.1055/s-0037-1603974. Epub 2017 Jul 21. PMID: 29134165; PMCID: PMC5680027.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 78 entries